Background {#Sec1}
==========

Pneumatosis intestinalis (PI) and the presence of hepatic portal venous gas (PVG) have long been thought to predict bowel necrosis and an associated poor prognosis \[[@CR1]--[@CR3]\]. However, widespread use of computed tomography (CT) has allowed better and more frequent detection of these conditions \[[@CR4], [@CR5]\]. PI and PVG are suggested to have various sequelae, including bowel necrosis, which are associated with poor patient outcomes. However, the diagnosis of bowel necrosis is often difficult in patients with PI and/or PVG. Accordingly, we investigated patients with PI/PVG to identify the predictors of bowel necrosis.

Methods {#Sec2}
=======

Study groups {#Sec3}
------------

Between January 2002 and January 2014, abdominal CT scan was used to diagnose PI/PVG in 57 patients at the National Center for Global Health and Medicine (Tokyo, Japan). Five patients were excluded from the study due to 1) disturbed consciousness or cardiopulmonary arrest upon arrival, 2) post-mortem CT, or 3) patient age \< 18 years. The remaining 52 patients were classified as having or not having bowel necrosis. Bowel necrosis was diagnosed based on surgical findings and/or postoperative pathologic examinations or autopsies. The clinical characteristics, laboratory/imaging findings, and condition severity of the patients in the two groups were compared to identify the indicators of bowel necrosis.

CT image interpretation {#Sec4}
-----------------------

Study group information was extracted from a database containing interpretations of imaging studies performed by experienced radiologists, using the key words: "pneumatosis intestinalis (PI)" and "portal venous gas (PVG)." Gas within 2 cm of the liver border in the contrast-enhanced images was defined as PVG \[[@CR1]\]. If a contrast-enhanced CT image showed a decrease in bowel wall enhancement, bowel ischemia was suspected.

PVG evaluation and PI distribution {#Sec5}
----------------------------------

Patients with PVG were evaluated to determine whether the amount of gas was a predictor of outcome. PVG generally expands from the left lobe of the liver to the right anterior lobe and then to the right posterior lobe as the amount of gas increases \[[@CR6]\]. Therefore, we compared patients with gas confined to the left lobe to those with gas in the right lobe or in both lobes. PI severity is reported to be related to its distribution \[[@CR7]\], so patients with PI were classified according to whether they had a bubble type or linear gas pattern.

Severity evaluation {#Sec6}
-------------------

Disease severity was evaluated using the following three scoring systems: (1) Acute Physiology and Chronic Health Evaluation II (APACHE II) score; (2) Sequential Organ Failure Assessment (SOFA) score; and (3) Systemic Inflammatory Response Syndrome (SIRS) score. These scores were calculated using clinical findings and laboratory parameters at the time PI/PVG was diagnosed.

Statistical analysis {#Sec7}
--------------------

Statistical analyses were performed using JMP 10 (SAS Institute, Cary, NC, USA). Univariate analyses were performed using chi-square and Fisher's exact tests; multivariate analyses were performed using logistic regression analysis. A probability (*P*) value \< 0.05 indicated statistical significance.

Results {#Sec8}
=======

Patient characteristics {#Sec9}
-----------------------

The 52 patients comprised 32 (61.5 %) men and 20 (38.5 %) women, with a mean age of 70.4 years (range, 19--97 years; median, 74 years) (Table [1](#Tab1){ref-type="table"}). Their underlying diseases included diabetes, respiratory disease, oncologic disease, collagen disease, cardiovascular disease, renal disease, hematological disorder, and inflammatory bowel disease; 16 patients (30.7 %) were taking steroids. Of the included patients, 17 were diagnosed with bowel necrosis, and 35 patients were determined not to have bowel necrosis. In patients with bowel necrosis, diagnoses included ileus (*n* = 6), non-occlusive mesenteric ischemia (NOMI; *n* = 3), superior mesenteric artery thromboembolism (*n* = 2), bowel perforation (*n* = 2), ischemic enteritis (*n* = 2), fatal toxic megacolon (*n* = 1), and postoperative abscess (*n* = 1). In patients without necrosis, diagnoses ranged from infectious enteritis to simple obstruction; the cause of symptoms was unknown in 11 patients. Of the 17 patients with bowel necrosis, 7 (41.2 %) survived, but required surgical intervention (Table [1](#Tab1){ref-type="table"}). Ten of the 17 patients died during their hospitalization. Of the 35 patients without necrosis, 2 died due to pneumonia. The incidence of postoperative PI/PVG detection was significantly higher in patients with bowel necrosis (*P* \< 0.0001); none of the other patient characteristics was associated with the incidence of detection.Table 1Patient characteristics, clinical findings, laboratory and computed tomography findingsTotalBowel necrosisNon-bowel necrosisNumber (N, (%))*N* = 52*N* = 17 (32.7)*N* = 35 (67.3)*P* valueAge70.4 ± 5.169.5 ± 8.970.9 ± 6.20.79Gender0.74 Male32 (61.5)1121 Female20 (38.5)614Underlying disease/condition/treatment Inflammatory bowel disease2 (3.8)020.31 Respiratory disease7 (13.5)250.8 Diabetes mellitus10 (19.2)370.84 α-Glucosidase inhibitor5 (9.6)140.52 Cardiovascular disease9 (17.3)450.41 Renal disease4 (7.7)220.44 Collagen disease7 (13.5)250.8 Hematological disease3 (5.8)030.21 Steroid therapy16 (30.8)4120.43 Chemotherapy8 (15.4)350.75 Postoperative state9 (17.3)810.0001 Tumor-bearing13 (25.0)580.61Abdominal findings Abdominal pain31 (59.6)14 (82.4)17 (48.6)0.019 Peritoneal irritation signs16 (30.8)9 (52.9)7 (20.0)0.016 Nausea/vomiting17 (32.7)7 (41.2)10 (28.6)0.36 Abdominal distension26 (50)11 (64.7)15 (42.9)0.14 Melena5 (9.6)1 (5.9)4 (11.4)0.52Vital signs Temperature36.9 ± 0.6637.1 ± 0.50.76 Mean blood pressure79.6 ± 8.986.9 ± 7.80.24 Pulse rate94.2 ± 13.685.6 ± 11.60.34 Respiration rate19.3 ± 2.617.9 ± 1.80.36Laboratory Findings WBC (×10^3^/μL)11,992 ± 28118654 ± 19880.16 Hb (g/dL)12.3 ± 0.9711.8 ± 0.680.39 Platelets (×10^3^/μL)18.9 ± 4.119.9 ± 2.90.67 Total bilirubin (mg/dL)1.16 ± 0.50.90 ± 0.350.39 Sodium (mmol/L)135.2 ± 3.2137.4 ± 2.30.26 Potassium (mmol/L)4.36 ± 0.344.2 ± 0.20.49 Arterial pH7.338 ± 0.0657.409 ± 0.0490.81 Base excess (mmol/L)−0.66 ± 0.321.22 ± 0.380.41 Bicarbonate (mmol/L)22.39 ± 3.6224.92 ± 2.610.28 Creatinine (mg/dL)1.7 ± 0.40.9 ± 0.30.0054 CRP (mg/dL)10.56 ± 4.013.15 ± 2.830.0038 Serum lactate (mmol/L)4.54 ± 2.031.90 ± 1.610.045Evaluation of Severity SIRS score1.1 ± 0.50.4 ± 0.30.036 APACHE II score12 ± 2.97.7 ± 2.10.022 SOFA score2.8 ± 0.91.2 ± 0.60.0044Computed tomography findingsAscites18 (34.6)10 (58.8)8 (22.9)0.011Free Air20 (38.5)5 (29.4)15 (42.9)0.35Pneumatosis intestinalis (PI)45 (86.5)14 (82.3)31 (88.6)0.54 linear pattern23 (51.1)10 (58.8)13 (37.1) bubble pattern22 (48.9)4 (23.5)18 (51.4)0.082Portal venous gas (PVG)20 (38.5)9 (52.9)11 (31.4)0.13 Left lobe12 (23.1)5 (29.4)7 (20) Right lobe or both lobes8 (15.4)4 (23.5)4 (11.4)0.71Both PI and PVG13 (25)6 (35.3)7 (20)0.23Deterioration in bowel wall enhancement17 (32.7)8 (47.1)9 (25.7)0.03Bubble pattern: gas bubbles in the bowel wallLinear pattern: continuous gas with a smooth margin

Clinical, laboratory, and imaging findings {#Sec10}
------------------------------------------

Clinical findings included abdominal pain, abdominal distension, nausea and vomiting, peritoneal irritation signs, and melena (Table [1](#Tab1){ref-type="table"}). A significant difference was observed between the two groups with respect to abdominal pain (*P* = 0.019) and peritoneal irritation signs (*P* = 0.016). Conversely, there were no significant differences in vital signs. There were also significant differences in the levels of C-reactive protein (CRP) (*P* = 0.0038), creatinine (*P* = 0.0054), and lactate (*P* = 0.045) between the two groups (Table [1](#Tab1){ref-type="table"}). In patients with bowel necrosis, levels of CRP (10.56 ± 4.01 mg/dL), creatinine (1.7 ± 0.4 mg/dL), and lactate (4.54 ± 2.03 mmol/L) were higher than the levels in patients without bowel necrosis. With respect to patient condition severity, statistically significant differences were found between patients with and without bowel necrosis in the APACHE II, SOFA, and SIRS scores. The APACHE II (12 ± 2.9), SOFA (2.8 ± 0.9), and SIRS (1.1 ± 0.5) scores were higher in patients with bowel necrosis. Among all patients, CT images revealed abdominal ascites in 18 (34.6 %) and free air in 20 (38.5 %) (Table [1](#Tab1){ref-type="table"}); bowel wall enhancement changes were observed in 17 patients (32.7 %).

PI was detected in 45 patients (86.5 %), and PVG was found in 20 (38.5 %), with 13 patients (25 %) exhibiting both; the presence of PI and/or PVG was not significantly related to bowel ischemia, however. Among the 20 patients with PVG, gas was confined to the left lobe in 12 patients and was seen in the right or in both lobes in 8. No gas location was significantly associated with obowel ischemia (*P* = 0.71). Bowel necrosis was more frequent in patients with a linear gas pattern, but the difference was not significant (*P* = 0.082). However, changes in bowel wall enhancement were significantly more frequent in patients with bowel necrosis (*P* = 0.03).

Treatment and outcomes {#Sec11}
----------------------

Surgery was performed on 11 (21.2 %) patients, and 41 (78.8 %) were treated conservatively (Table [2](#Tab2){ref-type="table"}). Operations included right hemicolectomy with massive bowel resection (*n* = 4), alleviation of ileus and partial small bowel resection (*n* = 2), intraperitoneal irrigation and drainage (*n* = 2), Hartmann's operation (*n* = 1), and exploratory laparotomy (*n* = 2). One patient who underwent exploratory laparotomy had a preoperative diagnosis of sigmoid colon necrosis, but the laparotomy did not reveal bowel necrosis. The other patient undergoing exploratory laparotomy had massive necrosis extending from the stomach to the large bowel, and definitive treatment was considered impossible. This patient died. Conservative treatment included bowel rest only (*n* = 13); observation plus antibiotic therapy (*n* = 17); decompression via a gastric/ileus tube (*n* = 6); oxygen therapy, including hyperbaric oxygen therapy (*n* = 3); and other treatments (*n* = 5). Bowel necrosis was suspected in 8 patients receiving conservative treatment, but laparotomies were not performed for various reasons. Seven of these 8 patients died from deterioration of their general condition due to bowel necrosis or the underlying disease. One patient, who probably had transient bowel ischemia, demonstrated an improved clinical state and achieved a good outcome.Table 2Operative method for PI/PVG patientsTreatmentTotalBowel necrosisNon-bowel necrosis*N* = 52*N* = 17 (32.7)*N* = 35 (67.3)*P* value∙ Surgery11 (21.2)10 (58.8)1 (2.9) Right hemicolectomy ± massive bowel resection440 Ileus surgery ± partial small bowel resection220 Hartmann's operation110 Intraperitoneal irrigation and drainage220 Exploratory laparotomy211∙ Conservative therapy41 (78.8)7 (41.2)33 (97.1) No oral treatment13013 No oral treatment + Antibiotic17512 Decompression via gastric tube624 Oxygen therapy303 Other505 In-hospital deaths12 (23.1)10 (58.8)2 (5.7)\<0.0001

Univariate/multivariate analyses {#Sec12}
--------------------------------

In univariate analyses, abdominal pain, peritoneal irritation, higher CRP, creatinine, and lactate, CT findings of ascites or reduced bowel wall enhancement, and linear PI pattern were associated with the presence of bowel necrosis. Postoperative patients with PI or PVG were more likely to have bowel necrosis than patients who had not had surgery (*P* = 0.003) (Table [3](#Tab3){ref-type="table"}).Table 3Multivariate analysis of predictors of bowel ischemiaVariable95 % CI*P* valueOdds ratioPostoperative detection (yes or no)0.142--7.050.0031.43Deterioration in bowel wall enhancement (yes or no)0.021--64.530.9510.894Abdominal pain (yes or no)0.0029--5.000.2340.1309Peritoneal irritation signs (yes or no)0.00083--17.140.2130.554Ascites (yes or no)0.545--2690.120.123Linear pneumatosis intestinalis pattern (yes or no)0.00183--2.790.2070.137Lactate (≥3 or \< 3 mmol/L)0.0892--14.950.681.96C-reactive protein (≥3 or \<3 mg/dl)0.0232--16.620.890.806Creatinine (≥1.2 or \< 1.2 mg/dl)0.0127--16.720.761.87*CI* Confidence interval

Characteristics of patients with postoperatively detected PI/PVG {#Sec13}
----------------------------------------------------------------

Postoperative PI/PVG was detected in 9 (17.3 %) patients (Table [4](#Tab4){ref-type="table"}). Eight had PI, 4 had PVG, and 3 had both. Eight of these patients had bowel necrosis; 5 died, and 3 were successfully treated with further surgical intervention. One patient developed PI/PVG and NOMI was suspected after aortic replacement for an abdominal aortic aneurysm; this individual was treated conservatively.Table 4Patients with postoperative pneumatosis intestinalis (PI)/portal venous gas (PVG)Bowel necrosisSexAge (y)PI/PVGPreoperative diagnosisInitial surgeryTime to postoperative PI/PVG (days)Postoperative diagnosisPostoperative treatmentOutcomeYesMale20PIAppendicitisAppendectomy7Postoperative abscessOpen abdominal drainageAliveYesFemale84PI/PVGSigmoid colon cancerSigmoidectomy3NOMIExploratory laparotomyDeadYesMale67PI/PVGPerforated appendicitisIntraperitoneal irrigation and drainage1Perforated appendicitisIntraperitoneal irrigation & drainageDeadYesFemale48PIMetastases of uterine cancer, obstructive ileusRadical hysterectomy + partial small bowel resection24Obstructive ileusObservation + antibiotic therapyDeadYesFemale56PISigmoid colon cancerSigmoidectomy3Anastomotic breakdownHartmann's operation + construction of artificial anusAliveYesMale74PI/PVGEsophageal cancerSubtotal esophagectomy6Toxic megacolonObservation + antibiotic therapyDeadYesFemale55PIUterine cancerTotal hysterectomy16Strangulated ileusIleus surgery + partial small bowel resectionAliveYesMale55PVGPancreatic head cancerPancreaticoduodenectomy15Postoperative pancreatic fistulaObservation + antibiotic therapyDeadNoMale82PVGAAAAortic replacement1NOMI suspicionObservation + antibiotic therapyAlive*NOMI* non-occlusive mesenteric ischemia, *AAA* abdominal aortic aneury

Discussion {#Sec14}
==========

PI is the presence of gas within the submucosa or subserosa of the intestine. A previous study found that the mean age of PI patients is 56.6 ± 19.4 years and that 57 % of patients were male \[[@CR8]\]. PI is a rare disease and is still poorly understood. Four main theories exist, positing that PI is caused by: (1) increased intraluminal pressure derived from intestinal obstruction, colonoscopy, or gastroenteric tumor (mechanical theory); (2) pulmonary alveolar rupture resulting from pulmonary diseases, such as chronic obstructive pulmonary disease or asthma (pulmonary theory); (3) gas produced by gas-forming bacteria that enter the mucosal barrier (bacterial theory); or (4) α-glucosidase inhibitors (chemical theory) \[[@CR9]\]. However, each theory alone also fails to account for the cause of PI \[[@CR2], [@CR3]\].

PVG is the presence of air in the portal venous system. The mechanism for the appearance of gas in the portal vein is also not well understood. There are two major theories: (1) gas dissects into the intestinal wall from the intestinal lumen, or lung and intestinal mucosal damage allows intraluminal gas to enter the venous system (Mechanical theory); and (2) gas-forming bacteria enter the mucosal barrier and produce gas within the intestinal wall, which then enters into the portal vein system (bacterial theory) \[[@CR4], [@CR10]\].

Previous reports have suggested that PI and PVG usually originate from bowel necrosis, via similar mechanisms, and are often detected concomitantly in clinical situations. However, PI and PVG have been studied and treated as independent symptoms in many publications. In the current report, we treated patients with PI and/or PVG as having one condition \[[@CR5]\].

PI was previously thought to predict poor outcomes due to the development of bowel necrosis, but DuBose et al. evaluated 500 patients with PI and reported that it was not necessarily associated with bowel necrosis \[[@CR8]\]. Similarly, PVG was also thought to be indicative of a poor prognosis due to the development of bowel necrosis. This is supported by the findings of Kinoshita et al., who reported that the overall mortality rate for patients with PVG was 39 %, increasing to 75 % in patients with bowel necrosis and only 11.7 % in patients without necrosis \[[@CR4]\]. Furthermore, 97 % of PVG cases were reported to be related to bowel necrosis \[[@CR11]\]. In recent years, the widespread use of CT has enabled increased detection of PI/PVG, showing that these clinical signs are not always predictive of a poor outcome. However, this is because bowel necrosis is not always found in some patients with PI and/or PVG. The increased sensitivity of CT scans has increased the detection of PI and PVG, increasing the difficulty of determining whether or not a patient with PI/PVG has bowel necrosis. Some authors have reported the development of therapeutic algorithms for treating PI/PVG \[[@CR5], [@CR12]\], but the wide variety of potential clinical features makes the development of an algorithm that is applicable to all patients with PI/PVG difficult.

Some clinical findings have also been suggested to predict bowel necrosis in patients with PI/PVG. Some reports suggested that bowel necrosis was associated with the distribution of PVG and bowel gas morphology, though conflicting reports have made this suggestion controversial \[[@CR7], [@CR13]--[@CR15]\]. Bowel necrosis could not be predicted from the distribution or extent of PVG/PI. The distribution of PVG was entirely unrelated to bowel necrosis, whereas linear PI had a nonsignificant association with bowel necrosis. Patient characteristics and past medical histories have been reported to influence the occurrence of PI/PVG \[[@CR15], [@CR16]\], but we found no such relationship. Many laboratory tests have also been reported to be useful for the diagnosis of PI/PVG. Some reports have suggested that blood lactate levels and acidosis, indicators of tissue necrosis, are predictive of outcomes \[[@CR8], [@CR17], [@CR18]\]. Our univariate analysis showed that elevated levels of lactate, C-reactive protein, and creatinine were significantly associated with bowel necrosis. These laboratory parameters are related to tissue necrosis, inflammation, and dehydration, suggesting that our findings are reasonable. Furthermore, abdominal physical examination findings are important predictors of bowel necrosis. In particular, signs of peritoneal irritation have been thought to be useful for diagnosing peritonitis due to bowel necrosis \[[@CR19]\]. Our study supported this contention, suggesting that both abdominal pain and signs of peritoneal irritation predict bowel necrosis. However, the assessment of physical findings is physician-dependent, making an objective or numerical expression of such findings difficult. Several scoring systems that evaluate patient condition severity have been put forth as useful prognostic indicators for patients with bowel necrosis \[[@CR20], [@CR21]\]. In this study, the SIRS, APACHE II, and SOFA scores were used to assess severity. All three scores were related to bowel necrosis, indicating that these scores can be useful for evaluating patients undergoing surgery or conservative treatment. Recently, procalcitonin and presepsin may indicate useful prognostic information for patients with severe sepsis or septic shock. These parameters are expected to be useful for evaluating the severity of patients' condition in the future \[[@CR22]\].

PI/PVG is more likely to indicate bowel necrosis in postoperative patients than in patients who have not had surgery. There are several reasons that postoperative PI/PVG may be an indicator of bowel necrosis. First, the proliferation of intestinal bacteria and the production of gas in the bowel increase the intraluminal pressure, particularly in patients with postoperative ileus; this may lead to bowel ischemia and PI/PVG. Second, inflammatory cytokines increase vascular permeability, and the resulting intravascular dehydration may cause bowel ischemia \[[@CR23]\]. In our study, the decrease in intravascular fluid, secondary to severe operative stress and perioperative catecholamine use, may have caused bowel ischemia in patients who underwent highly invasive surgeries, such as esophagectomies or pancreaticoduodenectomies. Third, the intestine can be damaged during abdominal surgery, and suture failure sometimes occurs after bowel resection and anastomosis. If there is massive leakage of bowel contents into the abdominal cavity, re-operation may be required due to bowel necrosis or peritonitis. Moreover, vasoconstrictors or vasopressors (e.g., catecholamines) are used if the patient's blood pressure is unstable. Although vasoconstrictors increase blood pressure, they may also compromise blood flow to the peripheral intestinal vessels. Excessive vasoconstriction or repeated alternation of vasoconstriction and vasodilatation may also induce mesenteric artery spasms, causing ischemic enteritis or NOMI \[[@CR24], [@CR25]\]. Diagnosis of PI/PVG in postoperative patients is thus a simple indicator of potential bowel necrosis and may be useful for determining treatment.

In many cases, PI or PVG occurs in patients who have not undergone surgery, and it appears to resolve spontaneously in many of these patients. This is because PI or PVG can occur due to transient and reversible intestinal ischemia under certain conditions. For example, gas-forming bacteria can enter the mucosal barrier, through mucosal rents or increased mucosal permeability, and produce gas within the bowel wall; alternatively, the intestinal wall may be injured, or increased intraluminal pressure may serve as the driving force in PI that causes the intramural gas, due to conditions such as intestinal obstruction, inflammatory bowel disease, bowel preparation, or colonoscopy.

Our study had several limitations, including being a retrospective, single-center investigation involving a small sample size. The PI/PVG and bowel ischemia diagnoses were dependent upon the subjective judgment of the attending physicians, leading to potential selection bias. Furthermore, this study did not evaluate patients with bowel necrosis who did not have PI and/or PVG, so the association between PI/PVG and bowel necrosis cannot be fully assessed. The pathogenesis and clinical significance of PI/PVG should thus be further investigated in future multicenter prospective studies.

Conclusion {#Sec15}
==========

In conclusion, postoperative detection of PI/PVG is indicative of bowel necrosis and is a useful indicator for surgeons deciding between further surgical intervention and conservative therapy.
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